Litcius/Paper detail

Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials

Anushua Sinha, Radha Railkar, Luis A. Castagnini, Andrea Guerra, Andrea Likos, Jeannine Lutkiewicz, Brian M. Maas, Xiaowei Zang, Brad Roadcap, Yoonyoung Choi, Georges J. Nahhas, Carmen Sofia Arriola, Louis Bont, Paolo Manzoni, Octavio Ramilo, Flor M. Muñoz, Lyn Finelli, Andrew W. Lee

2025Contemporary Clinical Trials11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineStage (stratigraphy)Respiratory systemMonoclonal antibodyPneumovirusClinical trialVirusPediatricsIntensive care medicineImmunologyAntibodyVirologyViral diseaseParamyxoviridaeInternal medicineBiologyPaleontologyRespiratory viral infections researchVirus-based gene therapy researchNeonatal Respiratory Health Research
Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials | Litcius